NCT06041607

Brief Summary

Although the benefits of meditation are increasingly well documented, few hospitals offer this integrative approach in their supportive cancer care. Meditation is sometimes provided, but its potential benefits remain insufficiently evaluated. This project is based on the hypothesis that there could be a benefit in meditating together.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 18, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

January 9, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2024

Completed
Last Updated

July 11, 2024

Status Verified

July 1, 2024

Enrollment Period

6 months

First QC Date

September 11, 2023

Last Update Submit

July 10, 2024

Conditions

Keywords

meditationcarer

Outcome Measures

Primary Outcomes (1)

  • To assess the possible added value for patients (target population) of a meditation programme shared between patients, carers and third parties, compared with the same meditation programme conducted solely for patients.

    Changes in self-efficacy scores according to the Generalized Self Efficacy Scale \[min 10; max 40\]

    measured at the end of the meditation programme (after the 12 weekly sessions) compared with the measurement at inclusion

Study Arms (2)

Shared meditation

EXPERIMENTAL

Shared" meditation: mixed groups of patients, carers and third parties

Behavioral: Shared meditation

Meditation "patients"

ACTIVE COMPARATOR

groups of patients only

Behavioral: Meditation with patients oly

Interventions

Meditation sessions between patients, carers and third parties * 12 weekly 2-hour sessions, * 2 half-day 3-hour retreats after the 9th session and at the end of the programme * 3 monthly follow-up sessions (2h) in remote format (videoconference)

Shared meditation

Meditation sessions between patients only * 12 weekly 2-hour sessions, * 2 half-day 3-hour retreats after the 9th session and at the end of the programme * 3 monthly follow-up sessions (2h) in remote format (videoconference)

Meditation "patients"

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Criteria for all participants (patients, carers and third parties)
  • Participant with no current or previous experience of regular or intensive meditation or comparable practice. Practice is considered regular and/or intensive if :
  • it occurs more than one day a week for more than 6 consecutive months over the last 10 years,
  • and/or more than 5 consecutive days of intensive practice (course or retreat) in the last 10 years,
  • and/or more than 25 consecutive days of retreat (cumulative) in the last 10 years.
  • Patient-specific criteria (target population) - Cancer patients (regardless of location)
  • Specific criteria for carers
  • \- All medical and/or paramedical care staff at the Centre François Baclesse in contact with patients (doctors, nurses, nursing assistants, radiotherapy technicians, etc.)
  • Specific criteria for third parties- Any volunteer not belonging to the two categories above

You may not qualify if:

  • Participants with significant vulnerability factors such as alcohol or drug dependence, severe depression, severe social anxiety, recent bereavement, etc.)
  • Participant unable to undergo trial monitoring for geographical, social or psychopathological reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre François Baclesse

Caen, France

Location

Related Publications (1)

  • Prevost V, Tran T, Leconte A, Lequesne J, Fernette M, Segura C, Chevigne S, Gouriot M, Clarisse B. A randomised study to evaluate the potential added value of shared meditation involving people with cancer, health professionals and third persons compared to meditation conducted with patients only: design of the Implic-2 protocol. BMC Cancer. 2024 Sep 4;24(1):1097. doi: 10.1186/s12885-024-12521-1.

MeSH Terms

Interventions

Meditation

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2023

First Posted

September 18, 2023

Study Start

January 9, 2024

Primary Completion

June 26, 2024

Study Completion

June 26, 2024

Last Updated

July 11, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations